Overweight & Obesity

Drug shows promise for genetic proopiomelanocortin deficiency

(HealthDay)—An experimental drug spurred substantial weight loss in patients with proopiomelanocortin (POMC) deficiency, according to a study published in the July 21 issue of the New England Journal of Medicine.

Overweight & Obesity

Study compares effectiveness of weight-loss drugs

In an analysis that included nearly 30,000 overweight or obese adults, compared with placebo, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide were each associated with achieving at least ...

Health

Makeover coming for food nutrition labels

A new look is coming to Nutrition Facts labels on food packages, with more attention to calorie counts and added sugars. And no longer will a small bag of chips count as two or three servings.

Overweight & Obesity

Can a new drug brown the fat and trim the obese person?

New research has found that a variant of a drug used to treat pulmonary arterial hypertension prompts weight loss in obese mice. Among mice fed a high-fat diet, those who did not get the medication became obese while medicated ...

Overweight & Obesity

Extreme obesity calls for individualized medication

Doctors and pharmacists often do not take obesity into account when prescribing medication. For this, more insight into the influence of obesity on the distribution and elimination of drugs is of the utmost importance. This ...

page 8 from 16